About the Author(s)
Max Robinson, Senior Lecturer in Oral Pathology, School of Dental Science, Newcastle University, UK, Keith Hunter, Professor of Head and Neck Pathology, Department of Oral Pathology, School of Clinical Dentistry, University of Sheffield, UK, Michael Pemberton, Consultant in Oral Medicine and Honorary Professor, University Dental Hospital of Manchester, Manchester University Hospitals NHS Foundation Trust, UK, and Philip Sloan, Professor of Oral Pathology, School of Dental Science, Newcastle University, UK
Max Robinson is an academic
pathologist at Newcastle University and an Honorary Consultant at Newcastle-upon-Tyne Hospitals NHS Foundation Trust, where he delivers a specialist head and neck pathology service. He leads teaching in oral diseases at Newcastle Dental School and has over 20 years experience of providing excellent undergraduate and postgraduate teaching. His research is focused on the pathogenesis of head and neck cancer, he has a program of research examining novel biomarkers and has strong links with commercial diagnostic companies. He is also lead pathologist for several UK multi-centre clinical trials.
Keith Hunter is Professor of Head and Neck Pathology at the University of
Sheffield. He completed his PhD at the Beatson Institute for Cancer Research (Glasgow), and was afterwards appointed as Senior Clinical Lecturer and Consultant Histopathologist at the University of Glasgow He moved to the University of Sheffield in 2009. His research focuses on the transcriptional changes seen in the various stages in the development of oral precancer and cancer with a particular interest in the control of cellular immortalization of oral keratinocytes. Clinically, he has a particular interest in tooth pathology and odontogenic tumours. He is the author of over 70 peer reviewed articles and has also contributed to a number of books.
Pemberton is a Consultant in Oral Medicine at Manchester University Hospitals NHS Foundation Trust and an Honorary Professor at the University of Manchester. He has dental and medical degrees from the University of Sheffield and is a fellow of the Faculty of Dental Surgery at the Royal College of Surgeons of England, and Edinburgh. Since 2009, he has held the position of Medical Director at the University Dental Hospital of Manchester.
Philip Sloan is a practicing pathologist specialising in head & neck, skin and bone & soft tissue pathology. He is co-director of the Newcastle MRC Molecular Pathology Node and Designated Individual for the NuTH Human Tissue Authority
research licence. After graduating from Newcastle University in 1974, he gained his PhD from the University of Bristol in 1978. He was Professor of Oral Pathology at the University of Manchester and R&D Director of CMHT until 2007 when he returned to his home city of Newcastle to take up his present appointment. Philip has published in the field of oral cancer and potentially malignant disorders. He has authored or co-authored over 200 peer reviewed publications, numerous book chapters and three books. He was lead author in 2017 for the WHO classification for oral cancer and is currently part of the writing team for ICCR guidelines relating to oral cancer and neck
"Review from previous edition [The book] will serve as an excellent ready reference." - Christopher Smith in Doody's Journal
"Oral Pathology should retain its place as "essential reading" in all dental curricula. Although this book is aimed at undergraduate dental students, I would not hesitate to recommend it as a useful book for general dental practitioners and postgraduate students aiming to further their knowledge in the field of oral pathology." - A. V. Jones in British Dental Journal, Vol.199, No.2, July 2005